What is the Otsuka Holdings Co., Ltd. stock price forecast?

Otsuka Holdings Co., Ltd. is currently trading at ¥10,230. View real-time AI analysis on Alpha Lenz.

What is Otsuka Holdings Co., Ltd. insider trading activity?

View the latest insider trading data for Otsuka Holdings Co., Ltd. on Alpha Lenz.

What is Otsuka Holdings Co., Ltd.'s P/E ratio?

Otsuka Holdings Co., Ltd.'s P/E ratio is 14.9.

Otsuka Holdings Co., Ltd.

JPX · 4578

¥10,230+30(+0.29%)Market closed

Ask about Otsuka Holdings Co., Ltd.'s future dividend policy...

Alpha Chat Insight

“Otsuka Holdings Co., Ltd. trades at a P/E of 14.9 (undervalued) with solid ROE of 12.6%. 3Y revenue CAGR of 12.4% highlights clear growth momentum.”

Ask for details →

Company Overview

Otsuka Holdings Co., Ltd. is a diversified healthcare company predominantly engaged in pharmaceuticals and nutraceuticals. Its core mission is centered on innovation within the life sciences domain, emphasizing the development of treatments and healthcare products that improve human health and longevity. The company notably impacts the global pharmaceutical industry with a robust portfolio that includes medications for central nervous system disorders, cardiovascular conditions, and oncology treatments. Otsuka Holdings extends its influence into the consumer health sector through its nutraceutical line, offering functional foods and beverages designed to support overall wellness. Established in 2008 and headquartered in Tokyo, Japan, Otsuka Holdings serves a broad market that spans across North America, Europe, and Asia, contributing significantly to medical advancements and health improvements worldwide.

CEOMr. Makoto Inoue

Websitehttps://www.otsuka.com

SectorHealthcare

IndustryDrug Manufacturers - General

Employees35,338

Company Statistics

FY 2025

Profile

¥5,422,918,427,190Market Cap

¥2,468,892,000,000Revenue

0.00Shares Out

35,338Employees

Margins

71.68%Gross

25.83%EBITDA

19.12%Operating

18.96%Pre-Tax

14.83%Net

Valuation

14.93P/E

1.79P/B

2.20EV/Sales

8.13EV/EBITDA

20.71P/FCF

Growth (CAGR)

12.41%Rev 3Yr

11.65%Rev 5Yr

36.39%Op Inc 3Yr

17.41%Op Inc 5Yr

38.69%Net Inc 3Yr

19.27%Net Inc 5Yr

Returns

9.23%ROA

12.59%ROE

12.48%ROIC

Financial Health

¥534,645,000,000Cash & Cash Equivalents

¥563,156,000,000Net Debt

35.42%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“Otsuka Holdings Co., Ltd. trades at a P/E of 14.9 (undervalued) with solid ROE of 12.6%. 3Y revenue CAGR of 12.4% highlights clear growth momentum.”

Ask for details →

Frequently Asked Questions

Otsuka Holdings Co., Ltd. (ticker: 4578) is a company listed on JPX in the Healthcare sector (Drug Manufacturers - General). It has approximately 35,338 employees. Market cap is $5.4T.

The current price is 10,230 with a P/E ratio of 14.93x and P/B of 1.79x.

ROE is 12.59% and operating margin is 19.12%. Annual revenue is $2.5T.